Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2021-12-15 Regulatory Filings
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number : 7941V' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' related to trading activity, which is a type of regulatory market announcement. Since this is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Delisting (DLST), the most appropriate fallback category for miscellaneous regulatory news disseminated via the RNS system is 'Regulatory Filings' (RNS). The document length is short (1914 chars), but it is the announcement itself, not an announcement *about* another report, so RPA is less suitable than RNS for this specific type of market operational notice.
2021-12-15 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number' and contains information about a 'Second Price Monitoring Extension' for a security, indicating a regulatory trading halt or price volatility notification on the London Stock Exchange. The text explicitly mentions 'RNS, the news service of the London Stock Exchange' and that RNS is approved by the Financial Conduct Authority (FCA). This type of immediate, short regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2021-12-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number : 6449V' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' related to trading, which is a specific type of market announcement. Since this is a general regulatory announcement disseminated via the RNS system and does not fit into the more specific categories like 10-K, ER, or DIV, the most appropriate classification is the general Regulatory Filings category.
2021-12-14 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 6316V' and explicitly mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS stands for Regulatory News Service, which is used for official regulatory announcements in the UK. The content itself is a brief update regarding a 'Second Price Monitoring Extension' for a security, which is a specific type of market operational announcement. Since this is a general regulatory announcement that doesn't fit into the more specific categories like DIV, ER, or 10-K, the most appropriate classification is the general regulatory filing category.
2021-12-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory announcement related to trading mechanics, not a comprehensive financial report or a standard corporate action like a dividend or management change. Given the nature of the announcement (a brief update on trading status) and the explicit reference to RNS, this falls best under the general 'Regulatory Filings' category, as it is a standard, non-specific regulatory notification disseminated via the RNS system.
2021-12-14 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 4426V'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, IR, or 10-K. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, or DLST), the most appropriate fallback category is Regulatory Filings (RNS).
2021-12-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.